These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17197824)

  • 21. [Efavirenz].
    Taéron C
    Rev Infirm; 2005 May; (111):37-8. PubMed ID: 15991644
    [No Abstract]   [Full Text] [Related]  

  • 22. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].
    van Leth F; Lange JM
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efavirenz-induced increase in HDL-cholesterol is influenced by the multidrug resistance gene 1 C3435T polymorphism.
    Alonso-Villaverde C; Coll B; Gómez F; Parra S; Camps J; Joven J; Masana L
    AIDS; 2005 Feb; 19(3):341-2. PubMed ID: 15718846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Positive change from protease inhibitor to non-nucleoside reverse transcriptase inhibitor efavirenz. Improved virus control thanks to protease inhibitor switch].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():37-8. PubMed ID: 11373775
    [No Abstract]   [Full Text] [Related]  

  • 25. [Efavirenz (Sustiva) in pregnancy: a study about 12 HIV patients].
    Jeantils V; Khuong MA; Delassus JL; Honoré P; Taverne B; Uzan M; Tassi S
    Gynecol Obstet Fertil; 2006; 34(7-8):593-6. PubMed ID: 16814587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of amitriptyline to offset sleep disturbances caused by efavirenz.
    Koppel BS; Bharel C
    AIDS Patient Care STDS; 2005 Jul; 19(7):419-20. PubMed ID: 16053397
    [No Abstract]   [Full Text] [Related]  

  • 27. [A "once daily" drug that with proven effectiveness. Efavirenz has successful outcome also in direct comparisons].
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():12-3. PubMed ID: 15011576
    [No Abstract]   [Full Text] [Related]  

  • 28. Photosensitive drug eruption induced by efavirenz in a patient with HIV infection.
    Furue M
    Intern Med; 2004 Jul; 43(7):533. PubMed ID: 15335175
    [No Abstract]   [Full Text] [Related]  

  • 29. A manic episode associated with efavirenz therapy for HIV infection.
    Shah MD; Balderson K
    AIDS; 2003 Jul; 17(11):1713-4. PubMed ID: 12853762
    [No Abstract]   [Full Text] [Related]  

  • 30. Efavirenz: enhancing the gold standard.
    Arribas JR
    Int J STD AIDS; 2003 Oct; 14 Suppl 1():6-14. PubMed ID: 14617398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probable interaction between efavirenz and cyclosporine.
    Tseng A; Nguyen ME; Cardella C; Humar A; Conly J
    AIDS; 2002 Feb; 16(3):505-6. PubMed ID: 11834972
    [No Abstract]   [Full Text] [Related]  

  • 32. Efavirenz-induced psychosis leading to involuntary detention.
    Poulsen HD; Lublin HK
    AIDS; 2003 Feb; 17(3):451-3. PubMed ID: 12556706
    [No Abstract]   [Full Text] [Related]  

  • 33. Undefined duration of opiate withdrawal induced by efavirenz in drug users with HIV infection and undergoing chronic methadone treatment.
    Boffito M; Rossati A; Reynolds HE; Hoggard PG; Back DJ; Di Perri G
    AIDS Res Hum Retroviruses; 2002 Mar; 18(5):341-2. PubMed ID: 11897035
    [No Abstract]   [Full Text] [Related]  

  • 34. Dose-ranging studies.
    Manion D
    Int J Clin Pract Suppl; 1999 Jun; 103():8-9. PubMed ID: 10622036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Issues in antiretroviral toxicity.
    Boyle BA
    AIDS Read; 2003 Oct; 13(10):459, 463-4, 468-9, 479. PubMed ID: 14596223
    [No Abstract]   [Full Text] [Related]  

  • 36. The first case of efavirenz-induced photosensitivity in a Japanese patient with HIV infection.
    Yoshimoto E; Konishi M; Takahashi K; Murakawa K; Maeda K; Mikasa K; Yamashina Y
    Intern Med; 2004 Jul; 43(7):630-1. PubMed ID: 15335197
    [No Abstract]   [Full Text] [Related]  

  • 37. Efavirenz intoxication due to slow hepatic metabolism.
    Hasse B; Günthard HF; Bleiber G; Krause M
    Clin Infect Dis; 2005 Feb; 40(3):e22-3. PubMed ID: 15668854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring.
    Gutiérrez F; Navarro A; Padilla S; Antón R; Masiá M; Borrás J; Martín-Hidalgo A
    Clin Infect Dis; 2005 Dec; 41(11):1648-53. PubMed ID: 16267739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Severe psychosis in an African woman due to the antiretroviral agent efavirenz].
    Oudijn MS; Vrijlandt CM; Casteelen G
    Ned Tijdschr Geneeskd; 2006 Mar; 150(11):643-4; author reply 644. PubMed ID: 16610510
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neurospychiatric symptoms in HIV infected patients and the role of efavirenz].
    Bary M; David F; Gasnault J; Kerneis H; Linard F; Longuet P; Pelissolo A; Ravaux I
    Med Mal Infect; 2004 Oct; 34(10):435-49. PubMed ID: 15747468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.